Revenue
No reported data
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Research & development | — | ¥0 | ¥0 | ¥35.0M | ¥60.0M | ¥78.0M | ¥167.0M | ¥84.0M | ¥89.0M | ¥207.0M |
| Operating expenses | ¥2.92T | ¥2.69T | ¥2.46T | ¥2.17T | ¥1.96T | ¥2.19T | ¥2.26T | ¥2.57T | ¥2.28T | ¥2.25T |
| Net income | ¥478.13B | ¥873.35B | ¥911.83B | ¥499.57B | ¥687.48B | ¥200.05B | ¥541.93B | ¥760.00B | ¥627.87B | ¥843.92B |
| Basic EPSper diluted share | ¥122.40 | ¥219.04 | ¥222.71 | ¥364.46 | ¥501.73 | ¥145.48 | ¥387.76 | ¥538.84 | ¥458.56 | ¥617.25 |
| Diluted EPSper diluted share | ¥122.36 | ¥218.98 | ¥222.63 | ¥364.31 | ¥501.49 | ¥145.39 | ¥387.49 | ¥538.43 | ¥458.18 | ¥616.83 |